Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC459 in asthma with rhinovirus challenge
NCT02660489Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jan 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in asthma, sponsored by Imperial College London. Started Jan 2015; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02660489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660489.